The aim of this study was to evaluate how konjac glucomannan hydrolysates (GMH) could support the healthy re-colonisation of vaginal microflora post infections. A total of 26 female patients (12 controls and 14 treatments) aged 18 to 25 suffering from vaginal infection were recruited for this study. Patients were assigned randomly into two groups to receive a standard antifungal treatment or a standard antifungal treatment plus pessary capsules containing 200 mg GMH (twice a week for thirty days). Patients were assessed on day zero, sixteen and thirty of the trial.
- konjac glucomannan hydrolysates
- antifungal agents
Tester, R., Al-Ghazzewi, F. H., Shen, N., Chen , Z., Yang, J., Zhang , D., & Tang , M. (2012). The use of konjac glucomannan hydrolysates to recover healthy microbiota in infected vaginas treated with an antifungal agent. Beneficial Microbes, 3(1), 61-66. https://doi.org/10.3920/BM2011.0021